Xylem Inc
XYL: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$973.00 | Wcxwtt | Zjqmlcsw |
Xylem: Investor Day Outlines Path to Above-Market Growth, but Shares Look Expensive
After reviewing Xylem's May 30 investor day presentation, we are raising our fair value estimate to $112 from $110, driven by our slightly more optimistic midcycle operating margin assumptions.